Literature DB >> 28178879

Prognostic significance of renal vascular pathology in lupus nephritis.

J M Mejía-Vilet1, B M Córdova-Sánchez1, N O Uribe-Uribe2, R Correa-Rotter1, L E Morales-Buenrostro1.   

Abstract

We performed a retrospective cohort analysis to define the prognostic significance of vascular lesions documented in renal biopsies of lupus nephritis patients. A total of 429 patients were segregated into five groups: (1) no vascular lesions (NVL), (2) arterial sclerosis (AS), (3) non-inflammatory necrotizing vasculitis (NNV), (4) thrombotic microangiopathy (TMA), and (5) true renal vasculitis (TRV). Renal outcomes were analyzed by Cox regression models, and correlations between vascular lesions and activity/chronicity scores were determined by Spearman's coefficients. A total of 200 (46.6%) had NVL, 189 (44.0%) AS, six NNV (1.4%), 23 (5.4%) TMA, and 11 (2.6%) TRV. Patients with NVL were younger, with higher renal function; patients with TMA and TRV had lower renal function and higher arterial pressure at baseline. Antiphospholipid syndrome and positive lupus anticoagulant were more frequently observed in the TMA group. Five-year renal survival was 83% for NVL, 63% for AS, 67% for NNV, 31% for TMA, and 33% for TRV. NNV and TRV were significantly correlated with activity scores, while AS and chronic TMA were correlated with chronicity scores. Renal vascular lesions are associated with renal outcomes but do not behave as independent factors. The addition of vascular lesions to currently used scores should be further explored.

Entities:  

Keywords:  Arterial sclerosis; lupus nephritis; renal biopsy; systemic lupus erythematosus; thrombotic microangiopathy; vascular

Mesh:

Substances:

Year:  2017        PMID: 28178879     DOI: 10.1177/0961203317692419

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  10 in total

1.  Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study.

Authors:  Savino Sciascia; Jinoos Yazdany; Maria Dall'Era; Roberta Fenoglio; Massimo Radin; Ishita Aggarwal; Maria J Cuadrado; Karen Schreiber; Antonella Barreca; Mauro Papotti; Dario Roccatello
Journal:  Ann Rheum Dis       Date:  2018-12-14       Impact factor: 19.103

Review 2.  A Histology-Guided Approach to the Management of Patients with Lupus Nephritis: Are We There Yet?

Authors:  Bogdan Obrișcă; Alexandra Vornicu; Alexandru Procop; Vlad Herlea; George Terinte-Balcan; Mihaela Gherghiceanu; Gener Ismail
Journal:  Biomedicines       Date:  2022-06-15

Review 3.  The non-haemostatic role of platelets in systemic lupus erythematosus.

Authors:  Petrus Linge; Paul R Fortin; Christian Lood; Anders A Bengtsson; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

4.  A case of lupus vasculopathy presenting favorable renal outcome.

Authors:  Yuri Ishizaki; Ayako Aizawa; Shoko Ochiai; Akihiro Minakawa; Shunichi Miyauchi; Kunihiko Umekita; Yuji Sato; Yayoi Ogawa; Yoshio Kushida; Akihiko Okayama; Noriko Uesugi; Shouichi Fujimoto
Journal:  CEN Case Rep       Date:  2019-12-20

Review 5.  Renal microvascular lesions in lupus nephritis.

Authors:  Ying Ding; Ying Tan; Zhen Qu; Feng Yu
Journal:  Ren Fail       Date:  2019-12-20       Impact factor: 2.606

6.  Kidney thrombotic microangiopathy in lupus nephritis: Impact on treatment and prognosis.

Authors:  David Massicotte-Azarniouch; Elizabeth Kotzen; Sarah Todd; Yichun Hu; Susan L Hogan; Koyal Jain
Journal:  Lupus       Date:  2022-06-01       Impact factor: 2.858

7.  Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.

Authors:  Juan M Mejia-Vilet; Ismael A Gómez-Ruiz; Cristino Cruz; R Angélica Méndez-Pérez; Roque A Comunidad-Bonilla; Norma O Uribe-Uribe; Carlos A Nuñez-Alvarez; Luis E Morales-Buenrostro
Journal:  Clin Rheumatol       Date:  2020-11-10       Impact factor: 2.980

Review 8.  Spontaneous perirenal hemorrhage in systemic lupus erythematosus: a rare case report and literature review.

Authors:  Youlu Zhao; Xiaoyu Jia; Xiaoqiang Tong; Guochen Niu; Rui Wang; Lijun Liu; Fude Zhou
Journal:  BMC Nephrol       Date:  2021-06-09       Impact factor: 2.388

Review 9.  Towards Precision Medicine in Systemic Lupus Erythematosus.

Authors:  Elliott Lever; Marta R Alves; David A Isenberg
Journal:  Pharmgenomics Pers Med       Date:  2020-02-04

Review 10.  Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations.

Authors:  Myrto Kostopoulou; Antonis Fanouriakis; Kim Cheema; John Boletis; George Bertsias; David Jayne; Dimitrios T Boumpas
Journal:  RMD Open       Date:  2020-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.